Evidence map›Paper›PMID 41099418›Full record

ArticleInternational journal of qualitative studies on health and well-being2025

"I want to live life, not just be in it!": a qualitative study on existential aspects of choosing to reduce or stop psychotropic medication.

Stine Madsen Kvaløy, Oddgeir Synnes, Anne Austad

Abstract read
In one paragraph

Article in International journal of qualitative studies on health and well-being, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stine Madsen KvaløyCentre for Diaconia and Professional Practice, VID Specialized University, Oslo, Norway.ORCID 0009-0004-5708-9648
Oddgeir SynnesCentre for Diaconia and Professional Practice, VID Specialized University, Oslo, Norway.ORCID 0000-0002-1976-4268
Anne AustadCentre for Diaconia and Professional Practice, VID Specialized University, Oslo, Norway.ORCID 0000-0001-5804-3247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWhile psychotropic medication is commonly used to treat severe mental illnesses, some patients perceive it as a barrier to meaningful aspects of their lives, motivating them to reduce or stop taking it. This qualitative study aims to contribute to the existential understanding of the choice to taper psychotropic medication.

methodsAn existential phenomenological method was employed, investigating and analyzing the lived experiences of 15 individuals in Norway in relation to their choice to taper their psychotropic medication with professional support.

resultsA drive towards existential health was identified, expressed through four types of quests: 1) the quest for a meaningful daily life, 2) the quest for a true self, 3) the quest for a deep sense of belonging with others, and 4) the quest to integrate spirituality in life.

conclusionsThis study indicates that the choice to reduce or stop taking psychotropic medication may encompass complex, existential dimensions beyond symptom management, affecting fundamental life aspects. For mental health professionals, these findings emphasize the importance of understanding these dimensions to better support individuals diagnosed with severe mental illness in their medication decisions and tapering processes.

Indexed as

Choice BehaviorExistentialismMental DisordersPsychotropic DrugsAdultAgedFemaleHumansMaleMiddle AgedNorwayQualitative ResearchQuality of LifeSpiritualityPsychotropic Drugsexistential healthexistential meaning-makinglived experienceMedication-free treatmentpsychotropic medication taperingspirituality

Identifiers

PMID41099418
PMCPMC12532359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.